Answer
The Byfavo product information recommends preferably avoiding remimazolam besylate during pregnancy as a precaution, because human pregnancy data are absent or limited, although animal studies indicate no direct or indirect reproductive harm.
Sources for this answer
- Byfavo 20mg powder for solution for injectionPAION UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked